Advanced olfactory training in post-COVID patients

Complexo Hospital de Clínicas da Universidade Federal do Paraná0 个研究点开始时间: 2022年1月23日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients who complain of anosmia or hyposmia after SARS-CoV-2 infection less than 3 months after symptom onset; convalescing from her COVID-19 disease, with onset of disease symptoms for at least 4 weeks; Patients who underwent RT-PCR test at symptom onset, with detection of SARS-CoV-2; Patients who can give valid written informed consent; Patients motivated to participate in the study; Adult patients aged 18-60 years.

•Patients who cannot give valid written informed consent; Patients with a previous history of more than one SARS-CoV-2 infection Patients with nasosinusal diseases such as chronic rhinosinusitis or nasal masses; History of previous traumatic brain injury with olfactory sequelae; History of olfaction disorder prior to SARS CoV-2 infection; Patients with any diagnosed neurological disease known to affect olfactory function; Patients unable to read Portuguese; Patients who are already using an oral glucocorticoid; Patients who have already started some form of therapy for the olfactory disorder caused by COVID-19; Known hypersensitivity to any item used in any of the proposed olfactory training;

发起方

Complexo Hospital de Clínicas da Universidade Federal do Paraná